Healthcare Industry News: cardiac monitor
News Release - June 20, 2006
Cardiac Science Granted Patent for Improved Defibrillator Cabinet'No-Draw' Circuit Protects Battery Life; Enhanced Design Triggers Alarm When AED is Removed
BOTHELL, Wash., June 20 (HSMN NewsFeed) -- Cardiac Science Corporation (Nasdaq: CSCX ), a global leader in advanced cardiac monitoring and external defibrillation products, announced today that it has been granted a patent by the U.S. Patent & Trademark Office for its Defibrillator Enclosure System, a cabinet for mounting automated external defibrillators (AED) in public spaces that emits an alarm once the device has been removed. Cardiac Science holds over 100 patents relating to proprietary technology, devices and disposables.
"This patent strengthens our growing intellectual property portfolio, as well as our position in the AED marketplace," said Garry Norris, vice president, marketing of Cardiac Science. "As the use of AEDs in public areas continues to expand, having an identifiable, easily accessible mounting unit can improve the life-saving potential of an AED. In an emergency, crucial seconds should not be lost hunting for a defibrillator. Furthermore, a dependable alarm that notifies other people close to the emergency situation can direct additional help to the rescuer and increase the likelihood of a life saving intervention."
Patent No. 7,020,520 covers various cabinet designs which involve a mechanism that triggers an alarm once the AED has been removed from the enclosure. The alarm is intended to alert those in the surrounding area that an emergency situation has occurred, improving the likelihood of additional assistance. The design also features a no-draw circuit that will not pull power from its battery until the AED is removed, protecting the battery for the critical moment.
Powerheart brand automated external defibrillators provide reliable, safe, and easy to use cardiac monitoring and defibrillation technology. Powerheart AEDs feature RHYTHMx(TM) software which detects abnormal heart rhythms, determines whether they are life-threatening, and only delivers a shock when needed. Powerheart AEDs also feature the patented RescueReady® technology, which automatically tests the device on a frequent basis to ensure continued functionality. Powerheart's STAR® Biphasic Waveform Technology provides levels of escalating energy customized to the patient. Powerheart AEDs are used by hospitals, police and fire departments, as well as many public access facilities including major corporations, public agencies, airlines and airports, arenas, schools, hotels, and casinos. For more information about Powerheart, go to www.powerheart.com.
About Cardiac Science Corporation
Cardiac Science Corporation develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, patient monitor-defibrillators and cardiology data management systems. Cardiac Science Corporation also sells a variety of related products and consumables, and provides a comprehensive portfolio of training, maintenance and support services.
The company is the successor to various entities that have owned and operated cardiology-related businesses, which sold products under the trusted brand names Burdick®, Powerheart®, and Quinton®. Cardiac Science Corporation is headquartered in Bothell, WA, and also has operations in Lake Forest, California, Deerfield, Wisconsin, Shanghai, China, Copenhagen, Denmark and Manchester, United Kingdom.
Forward Looking Statements
This press release contains forward-looking statements. The word "believe," "expect," "intend," "anticipate," and variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Forward looking statements in this press release include, but are not limited to, those that infer that Cardiac Science Corporation's revenue may grow in the future as a result of patents that we hold or have recently been issued. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks are more fully described in the 10-K filed by Cardiac Science Corporation for the year ended December 31, 2005. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.
Source: Cardiac Science
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.